Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Jerry Callahan
AddedMar 31, 2024
UpdatedMay 1, 2026
Jerry Callahan

Jerry Callahan

Co-Founder, Hopen Life Science Ventures

Jerry Callahan's Career

Hopen Life Science Ventures
Hopen Life Science Ventures

Grand Rapids, MI, US

Co-Founder
Metabolic Solutions Development
Metabolic Solutions Development

Kalamazoo, MI, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Jerry Callahan's Career

Hopen Life Science Ventures
Hopen Life Science Ventures
Investment FirmInvestment Firm72008Grand Rapids, MI, US
Co-Founder

Leadership at Hopen Life Science Ventures

Robert HackenbergRobert HackenbergCo-Founder
Mark OlesnavageMark OlesnavageCo-Founder

Similar to Hopen Life Science Ventures

Healthcare VenturesHealthcare VenturesCambridge, MA, USest. 1995Healthcare VenturesCambridge, MA, US · est. 1995

Healthcare Ventures LLC: A Massachusetts-based venture capital firm investing in early-stage life science companies.

Investment Firm11
LifeSci Venture PartnersLifeSci Venture PartnersNew York City, NY, USest. 2017LifeSci Venture PartnersNew York City, NY, US · est. 2017

LifeSci Venture Partners, formed in 2017, is an early-stage investment firm in life sciences and healthcare.

Investment Firm5
30Ventures30VenturesMadison, WI, USest. 201830VenturesMadison, WI, US · est. 2018

30Ventures: A Midwest-based venture capital firm specializing in early-stage healthcare and biotech innovations.

Investment Firm2
Nan Fung Life SciencesNan Fung Life SciencesSan Francisco, CA, USest. 2017Nan Fung Life SciencesSan Francisco, CA, US · est. 2017

Nan Fung Life Sciences: A global investment platform specializing in life sciences sector.

Investment Firm30
Metabolic Solutions Development
Metabolic Solutions Development
Series B$58.5M142011Kalamazoo, MI, US
Board Member· Board

Leadership at Metabolic Solutions Development

Stephen BenoitStephen BenoitBoard Member
Jerry ColcaJerry ColcaBoard Member
Rolf KletzienRolf KletzienBoard Member
Mike JandernoaMike JandernoaBoard Member
Robert ZerbeRobert ZerbeBoard Member
William U ParfetWilliam U ParfetBoard Member

Similar to Metabolic Solutions Development

Cirius TherapeuticsCirius TherapeuticsKalamazoo, MI, USPharmaceuticalsest. 2015Cirius TherapeuticsKalamazoo, MI, US · est. 2015

Cirius Therapeutics: A Michigan-based pharmaceutical company specializing in insulin sensitizers.

Series A · $49M30
Restor MetabolixRestor MetabolixMarietta, GA, USDiabetic Treatments, Metabolic Treatmentsest. 2021Restor MetabolixMarietta, GA, US · est. 2021

Restor Metabolix, a Georgia-based firm, offers scientifically proven diabetic treatments and metabolic disorder solutions, focusing on insulin desensitization.

Pre-Seed · $1M17

Jerry Callahan's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · Dunamu

People Similar to Jerry Callahan

Dan DiPofiDan DiPofiBoard Member · Twinlab Consolidated HoldingsDavid BlechmanDavid BlechmanFounder · TwinlabMike StoneMike StoneFounder · FS InvestorsJoe TianJoe TianCo-Founder · DT Capital PartnersPaul IaffaldanoPaul IaffaldanoBoard Member · VoAppsJosef ZankowiczJosef ZankowiczCo-Founder · NXM Labs